Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 23 Burkitt Lymphoma 15 Sarcoma 13 Lymphoma, Follicular 12 Neoplasms 11 Lymphoma 11 Hodgkin Disease 9 Breast Neoplasms 9 Triple Negative Breast Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, Non-Hodgkin 8 Endometrial Neoplasms 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Ovarian Neoplasms 7 Lymphoma, B-Cell 7 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5 Wilms Tumor 4 Recurrence 4 Osteosarcoma 4 Neoplasm Metastasis 4 Liposarcoma 4 Leukemia, Biphenotypic, Acute 4 Fallopian Tube Neoplasms 4 Sarcoma, Ewing 3 Neuroblastoma 3 Lymphoproliferative Disorders 3 Lymphoma, T-Cell 3 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Lymphocytic, Chronic, B-Cell 3

Interventions

nirogacestat 4 Specimen Handling 3 X-Rays 2 Phantoms, Imaging 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 trifluridine tipiracil drug combination 1 Oxaliplatin 1 Leucovorin 1 Ipilimumab 1 Fluorouracil 1 Electrochemotherapy 1 Doxorubicin 1 Cryosurgery 1 CTLA-4 Antigen 1 Bone Density 1 Blood Specimen Collection 1 Bleomycin 1 Biopsy 1 Bevacizumab 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Desmoid Tumors × Doxorubicin × 90 days × Clear all

NCT06268457 2026-05-14

Embodesmo

Istituto Ortopedico Rizzoli

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡